CA Patent

CA2463441A1 — Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity

Assigned to Bayer Pharmaceuticals Corp · Expires 2003-05-08 · 23y expired

What this patent protects

This invention relates to novel heterocyclic compounds, compositions, and methods for treating or preventing obesity and obesity-related diseases.

USPTO Abstract

This invention relates to novel heterocyclic compounds, compositions, and methods for treating or preventing obesity and obesity-related diseases.

Drugs covered by this patent

Patent Metadata

Patent number
CA2463441A1
Jurisdiction
CA
Classification
—
Expires
2003-05-08
Drug substance claim
No
Drug product claim
No
Assignee
Bayer Pharmaceuticals Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.